Cibc World Markets Corp Incyte Corp Transaction History

Cibc World Markets Corp

$13.5 Billion
Q3 2024

A detailed history of Cibc World Markets Corp transactions in Incyte Corp stock. As of the latest transaction made, Cibc World Markets Corp holds 21,851 shares of INCY stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,851

Previous 20,704 5.54%

Holding current value

$1.66 Million

Previous $1.26 Million 15.06%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$57.33 - $68.61 $65,757 - $78,695	1,147 Added 5.54%	21,851 $1.44 Million
Q2 2024 Aug 12, 2024	BUY	$51.18 - $63.75 $97,088 - $120,933	1,897 Added 10.09%	20,704 $1.26 Million
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $297,170 - $349,930	-5,255 Reduced 21.84%	18,807 $1.07 Million
Q4 2023 Feb 13, 2024	SELL	$52.16 - $64.19 $4.5 Million - $5.53 Million	-86,204 Reduced 78.18%	24,062 $1.51 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $5.12 Million - $5.84 Million	88,575 Added 408.35%	110,266 $6.37 Million
Q2 2023 Aug 04, 2023	BUY	$60.95 - $75.51 $751,696 - $931,264	12,333 Added 131.79%	21,691 $1.35 Million
Q1 2023 May 11, 2023	SELL	$70.23 - $86.01 $867,410 - $1.06 Million	-12,351 Reduced 56.89%	9,358 $676,000
Q4 2022 Feb 09, 2023	BUY	$67.18 - $84.11 $1.46 Million - $1.83 Million	21,709 New	21,709 $1.74 Million
Q2 2022 Aug 12, 2022	SELL	$66.18 - $83.18 $1.69 Million - $2.13 Million	-25,560 Reduced 66.04%	13,144 $999,000
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $217,469 - $262,564	3,294 Added 9.3%	38,704 $3.07 Million
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $991,271 - $1.16 Million	-15,650 Reduced 30.65%	35,410 $2.6 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $2.45 Million - $3 Million	35,698 Added 232.38%	51,060 $3.51 Million
Q2 2021 Aug 10, 2021	SELL	$79.87 - $87.53 $867,707 - $950,925	-10,864 Reduced 41.42%	15,362 $1.29 Million
Q1 2021 May 07, 2021	SELL	$76.02 - $100.5 $2.1 Million - $2.78 Million	-27,651 Reduced 51.32%	26,226 $2.13 Million
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $1.56 Million - $1.89 Million	19,315 Added 55.89%	53,877 $4.69 Million
Q3 2020 Nov 12, 2020	BUY	$85.07 - $109.69 $235,643 - $303,841	2,770 Added 8.71%	34,562 $3.1 Million
Q2 2020 Aug 12, 2020	BUY	$74.18 - $108.93 $67,132 - $98,581	905 Added 2.93%	31,792 $3.31 Million
Q1 2020 May 12, 2020	SELL	$63.18 - $85.97 $3.27 Million - $4.45 Million	-51,817 Reduced 62.65%	30,887 $2.26 Million
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $792,045 - $1.04 Million	10,844 Added 15.09%	82,704 $7.22 Million
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $1.54 Million - $1.83 Million	21,191 Added 41.82%	71,860 $5.33 Million
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $598,599 - $722,195	8,142 Added 19.15%	50,669 $4.31 Million
Q1 2019 May 14, 2019	SELL	$63.56 - $88.17 $3.61 Million - $5.01 Million	-56,851 Reduced 57.21%	42,527 $3.66 Million
Q4 2018 Feb 13, 2019	BUY	$58.5 - $69.94 $2.66 Million - $3.18 Million	45,459 Added 84.31%	99,378 $6.32 Million
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $915,073 - $1.1 Million	14,819 Added 37.9%	53,919 $3.73 Million
Q2 2018 Aug 13, 2018	BUY	$60.85 - $83.98 $397,715 - $548,893	6,536 Added 20.07%	39,100 $2.62 Million
Q1 2018 May 11, 2018	SELL	$83.06 - $100.98 $1.84 Million - $2.23 Million	-22,097 Reduced 40.43%	32,564 $2.71 Million
Q4 2017 Feb 13, 2018	BUY	$93.56 - $116.6 $1.23 Million - $1.53 Million	13,107 Added 31.54%	54,661 $5.18 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $4.54 Million - $5.75 Million	41,554	41,554 $4.85 Million

Others Institutions Holding INCY

# of Institutions

641

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Incyte Corp Transaction History